Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) France
Research
Date range: 1 March 2021 - 28 February 2022
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) published between 1 March 2021 - 28 February 2022 which are tracked by the Nature Index.
Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
Count | Share |
---|---|
2 | 0.01 |
Outputs by subject (Share)
Subject | Count | Share |
---|---|---|
Life Sciences | 2 | 0.01 |
Share output for the past 5 years
2016 | 2017 | 2018 | 2019 | 2020 |
---|---|---|---|---|
0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Collaboration
Date range: 1 March 2021 - 28 February 2022
International vs. domestic collaboration by Share
- 49.02% Domestic
- 50.98% International
Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators with Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) by Share (29 total)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and Assistance Publique-Hôpitaux de Paris (AP-HP)
(0.29)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and Paris-Cardiovascular Research Center (PARCC)
(0.21)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and National Institute for Health and Medical Research (INSERM)
(0.18)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and University of Paris
(0.13)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and Nutrition and Obesities
(0.08)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and Metagenopolis (MGP)
(0.07)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and AgroParisTech
(0.07)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and Sorbonne University
(0.07)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and Institute of Cardiometabolism and Nutrition (ICAN)
(0.05)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and Risk Factors and Molecular Determinants of Aging-related Diseases (RID-AGE)
(0.03)
Top 10 international collaborators with Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) by Share (62 total)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and University of Michigan (U-M)
(0.22)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and National Institute of Cardiology
(0.12)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and University of Copenhagen (UCPH)
(0.12)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and Mount Sinai Health System (MSHS)
(0.09)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and Mayo Clinic
(0.08)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and Imperial College London (ICL)
(0.07)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and Catholic University of Louvain (UCLouvain)
(0.06)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and European Molecular Biology Laboratory (EMBL)
(0.05)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and Biobyte Solutions GmbH
(0.05)
-
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) and Maastricht University (UM)
(0.05)
Relationships
Partner Institutions
Centre d'Investigation Clinique - Epidémiologie Clinique (CIC-EC 1418) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.